Alain Dupuy
University of Rennes
154 Papers
462 Citations
Alain Dupuy is an academic researcher from University of Rennes. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 30, co-authored 127 publications. Previous affiliations of Alain Dupuy include French Institute of Health and Medical Research.
Chat about Author
Papers
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Pascal Joly,Maud Maho-Vaillant,Catherine Prost-Squarcioni,Vivien Hébert,Estelle Houivet,Sébastien Calbo,Frédérique Caillot,Marie-Laure Golinski,Bruno Labeille,Catherine Picard-Dahan,Carle Paul,Marie-Aleth Richard,Jean-David Bouaziz,Sophie Duvert-Lehembre,Philippe Bernard,Frédéric Caux,Marina Alexandre,Saskia Ingen-Housz-Oro,Pierre Vabres,Emmanuel Delaporte,Gaëlle Quéreux,Alain Dupuy,Sébastien Debarbieux,Martine Avenel-Audran,Michel D'Incan,Christophe Bedane,Nathalie Beneton,Denis Jullien,Nicolas Dupin,Laurent Misery,Laurent Machet,Marie Beylot-Barry,Olivier Dereure,Bruno Sassolas,Thomas Vermeulin,Jacques Benichou,P. Musette +36 more
TL;DR: Data from this trial suggest that first-line use of rituximab plus short-termprednisone for patients with pemphigus is more effective than using prednisone alone, with fewer adverse events.
508
WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.
Karl Balabanian,Bernard Lagane,José L. Pablos,Lysiane Laurent,Thierry Planchenault,Olivier Verola,Céleste Lebbé,D. Kerob,Alain Dupuy,Olivier Hermine,Jean-François Nicolas,Véronique Latger-Cannard,Danièle Bensoussan,Pierre Bordigoni,Françoise Baleux,Françoise Le Deist,Jean-Louis Virelizier,Fernando Arenzana-Seisdedos,Françoise Bachelerie +18 more
TL;DR: It is proposed that the sustained CXCR4 activity in patient cells accounts for the immune-hematologic clinical manifestations and the profusion of warts characteristic of the WHIM syndrome.
346
Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis.
Laurence Fardet,Alain Dupuy,M. Gain,Adrien Kettaneh,P. Chérin,Hervé Bachelez,Louis Dubertret,Céleste Lebbé,Patrice Morel,Michel Rybojad +9 more
TL;DR: A retrospective study on adult patients with a definite or probable diagnosis of DM according to Bohan and Peter criteria or with amyopathic DM who were referred to 2 departments during a 13-year period to help physicians focus on a group of patients who might benefit from extensive evaluation for malignancy.
139
Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas.
Emmanuelle Tancrède-Bohin,Marius A Ionescu,Pauline De La Salmonière,Alain Dupuy,Jacqueline Rivet,Michel Rybojad,Louis Dubertret,Hervé Bachelez,Céleste Lebbé,Patrice Morel +9 more
TL;DR: Results strongly suggest that blood eosinophilia at baseline is a prognostic factor in patients with primary cutaneous T-cell lymphoma.
109
Human herpesvirus 8-associated hemophagocytic lymphohistiocytosis in human immunodeficiency virus-infected patients
Laurence Fardet,L. Blum,Delphine Kerob,Félix Agbalika,Lionel Galicier,Alain Dupuy,Matthieu Lafaurie,Véronique Meignin,P. Morel,C. Lebbá +9 more
TL;DR: HIV-8-related HL is associated with life-threatening symptoms and biological HHV-8 reactivation, and it may be controlled in the long term by etoposide therapy combined with highly active antiretroviral therapy.